Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
REGNRegeneron Pharmaceuticals	$105.45bn	27.29	n/a
VRTXVertex Pharmaceuticals	$103.66bn	28.87	n/a
MRNAModerna	$47.90bn	n/a	n/a
SGENSeagen	$43.15bn	n/a	n/a
IQVIqvia Holdings	$40.70bn	28.86	n/a
ICLRIcon	$25.55bn	34.17	n/a
BNTXBioNTech SE	$22.04bn	21.8	n/a
ALNYAlnylam Pharmaceuticals	$19.27bn	n/a	n/a
NBIXNeurocrine Biosciences	$14.16bn	38.27	n/a
SRPTSarepta Therapeutics	$12.63bn	n/a	n/a
KRTXKaruna Therapeutics	$12.58bn	n/a	n/a
MEDPMedpace Holdings	$12.16bn	40	n/a
TECHBIO-TECHNE	$12.15bn	53.69	0.41%
CRLCharles River Laboratories International	$12.03bn	29.48	n/a
UTHRUnited Therapeutics	$11.64bn	12.39	n/a
EXASExact Sciences	$11.41bn	n/a	n/a
RXDXPrometheus Biosciences	$9.56bn	n/a	n/a
QGENQiagen NV	$9.53bn	25.8	n/a
IMGNImmunoGen	$8.72bn	n/a	n/a
VKTXViking Therapeutics	$8.49bn	n/a	n/a